Navigating High-Risk TAVI: A Success Story for Patients wiht Severe Heart Disease & Cirrhosis
You’re facing a complex medical scenario: an elderly patient with a severely compromised heart and advanced liver disease, coupled with a heightened risk of bleeding. This is a situation that demands careful consideration and a highly specialized approach. At Medicover Hospitals, led by Dr. Tamiruddin A. Danwade,we recently successfully navigated just such a challenge,demonstrating that even seemingly untreatable patients can benefit from advanced interventions.
This case underscores a growing trend in cardiology – expanding the possibilities of Transcatheter Aortic Valve Implantation (TAVI) to a wider, more vulnerable patient population. LetS break down the details and what makes this approach so meaningful.
The Patient’s Complex Condition
Our patient was an 80-year-old gentleman presenting with worsening breathlessness. His medical history was already significant,including:
A previous heart bypass surgery (10 years prior).
A pacemaker implantation (5 years prior) due to complete heart block.
Established cirrhosis stemming from non-Alcoholic Steatohepatitis (NASH), diagnosed two years earlier, resulting in critically low platelet counts.
Further examination revealed a severe aortic stenosis – a narrowing of the aortic valve – and a significantly reduced heart pumping efficiency (LVEF of just 30%). This combination presented a formidable challenge. Open-heart surgery was deemed far too risky given the advanced cirrhosis and low platelet levels.
Why Customary Surgery Was Off the Table
Patients with advanced liver cirrhosis and low platelet counts face a dramatically increased risk of complications from open-heart surgery. The primary concerns include:
Uncontrolled bleeding: Cirrhosis impairs the liver’s ability to produce clotting factors, and low platelets exacerbate this risk.
Prolonged ICU Stay: Complications frequently enough necessitate extended intensive care.
Increased Mortality: The overall risk of death is significantly higher.
So, what alternatives exist when traditional surgery isn’t viable?
The Power of a Multidisciplinary Approach & TAVI
The Heart Team at Medicover – comprised of cardiologists, hepatologists, hematologists, and anesthesiologists – convened under the leadership of Dr. Danwade. After a thorough evaluation, we resolute that Transcatheter Aortic Valve Implantation (TAVI) offered the best, and possibly only, chance for a positive outcome.
TAVI is a minimally invasive procedure that replaces the narrowed aortic valve without requiring open-heart surgery.This significantly reduces the risks associated with a more invasive approach.
The Procedure: A minimalist Strategy
We performed a transfemoral TAVI under local anesthesia. this involved:
- Carefully accessing the femoral artery in the leg.
- Guiding a 29 mm Meryl Myval valve to the aortic valve.
- precisely deploying the new valve.
Recognizing the patient’s dangerously low platelet count, we proactively administered a single unit of platelets for added safety. The procedure was remarkably smooth, with the patient remaining stable throughout.
Remarkable Results & Rapid Recovery
The outcome was truly encouraging. The patient experienced:
No bleeding or vascular complications.
The ability to walk within 12 hours.
Discharge home within 48 hours.
Prescription of a single antiplatelet agent – a significant reduction in medication burden.
Why This Case is a Turning Point
This case is notably noteworthy as patients with cirrhosis and severely low platelets are frequently enough excluded from consideration for TAVI. The fear of complications is understandable, but our experience demonstrates that a carefully planned and executed TAVI procedure can be both safe and effective.
recent research supports this approach. Studies are increasingly showing that:
single Antiplatelet Therapy (SAPT): Using SAPT instead of the traditional dual antiplatelet therapy reduces bleeding risk in high-risk patients.
Minimalist Techniques: Adopting a less invasive approach minimizes trauma and further reduces the potential for complications.
Expanding the Scope of TAVI: A New Era in Cardiac Care
For this patient, TAVI wasn’t just a medical procedure; it was a restoration of quality of life. For the Medicover team, it was a powerful reminder that clinical trials provide valuable guidance, but real-world experience often allows us to push the boundaries of what’